Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (281-290 of 367) with videos related to

Pageof 37
Sort By:
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2022
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapySalvatore Pece, Ivana Sestak, Francesca Montani, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
Pathology|September 22, 2010
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancerSakunthala C Kudahetti, Gabrielle Fisher, Laurence Ambroisine, et al.
International Journal of Cancer|March 15, 2020
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screeningJack Cuzick, Rachael Adcock, Francesca Carozzi, et al.
International Journal of Cancer|February 18, 2018
Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or moreAnnarosa Del Mistro, Rachael Adcock, Francesca Carozzi, et al.
Vaccine|November 1, 2008
Recommendations for cervical cancer prevention in Asia PacificSuzanne M Garland, Jack Cuzick, Efren J Domingo, et al.
The Lancet Regional Health. Europe|May 13, 2022
Dementia risk in a diverse population: A single-region nested case-control study in the East End of LondonPhazha L K Bothongo, Mark Jitlal, Eve Parry, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2005
A multicentre epidemiological study on sunbed use and cutaneous melanoma in EuropeVéronique Bataille, Mathieu Boniol, Esther De Vries, et al.
Journal of the National Cancer Institute|December 10, 2024
Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United StatesCosette M Wheeler, Rachael Adcock, William C Hunt, et al.
Pageof 37

Showing results (281-290 of 367) with videos related to

Sort By:
Pageof 37
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2022
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapySalvatore Pece, Ivana Sestak, Francesca Montani, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
Pathology|September 22, 2010
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancerSakunthala C Kudahetti, Gabrielle Fisher, Laurence Ambroisine, et al.
International Journal of Cancer|March 15, 2020
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screeningJack Cuzick, Rachael Adcock, Francesca Carozzi, et al.
International Journal of Cancer|February 18, 2018
Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or moreAnnarosa Del Mistro, Rachael Adcock, Francesca Carozzi, et al.
Vaccine|November 1, 2008
Recommendations for cervical cancer prevention in Asia PacificSuzanne M Garland, Jack Cuzick, Efren J Domingo, et al.
The Lancet Regional Health. Europe|May 13, 2022
Dementia risk in a diverse population: A single-region nested case-control study in the East End of LondonPhazha L K Bothongo, Mark Jitlal, Eve Parry, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2005
A multicentre epidemiological study on sunbed use and cutaneous melanoma in EuropeVéronique Bataille, Mathieu Boniol, Esther De Vries, et al.
Journal of the National Cancer Institute|December 10, 2024
Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United StatesCosette M Wheeler, Rachael Adcock, William C Hunt, et al.
Pageof 37